Rational Fluid Therapy in Germany (RaFTinG)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01122277|
Recruitment Status : Unknown
Verified October 2010 by Ludwig-Maximilians - University of Munich.
Recruitment status was: Active, not recruiting
First Posted : May 13, 2010
Last Update Posted : July 8, 2011
|Condition or disease|
|Patients in ICU|
The purpose of RaFTinG is the prospective documentation and evaluation of the demographic, diagnostic and therapeutic characteristics of unselected patients and their treatment in intensive care units (ICU) in Germany.
Documentation will not only include their stay in the ICU but a follow up query 90 days after discharge from the ICU.
|Study Type :||Observational|
|Estimated Enrollment :||4000 participants|
|Official Title:||Klinisches Register RaFTinG - Rational Fluid Therapy in Germany|
|Study Start Date :||May 2010|
|Actual Primary Completion Date :||May 2011|
|Estimated Study Completion Date :||October 2011|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01122277
|Klinik für Anaesthesiologie, Klinikum der Universität München|
|Munich, Bavaria, Germany, 80336|
|Münster, Nordrhein - Westfalen, Germany, 48149|
|Principal Investigator:||Matthias Jacob, MD||Klinik für Anaesthesiologie, Klinikum der Universität München|
|Principal Investigator:||Christian Ertmer, MD||Universitätsklinikum Münster, Germany|
|Study Chair:||Bernhard Zwissler, Prof||Klinik für Anaesthesiologie, Klinikum der Universität München, Germany|
|Study Chair:||Hugo van Aken, Prof||Universitätsklinikum Münster, Germany|